Outpatient Versus Inpatient Care Pathway for Intra-arterial Treatment of Primary Liver Cancer (CHOC)
Condition(s) studied
Investigational drug(s) / intervention(s)
Ambulatory care: Patients with Hepato cellular carcinoma (HCC) and Intrahepatic cholangiocarcinoma (iCCA) treated by transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) are managed on an outpatient basis: hospitalization in an outpatient unit, followed by systematic telephone and on-demand nursing follow-up for 48 hours for TARE and 72 hours for TACE. A dedicated re-hospitalization circuit has also been set up in the event of complications.
Conventional inpatient care: Patients with Hepato cellular carcinoma (HCC) and Intrahepatic cholangiocarcinoma treated by transarterial chemoembolization (TACE) or transarterial radioembolization (TARE) are managed on an inpatient basis: conventional hospitalization.
Study summary
Randomized multicentre trial comparing two care organisations (ambulatory vs conventional inpatient) for patients undergoing transarterial chemoembolization (TACE) or radioembolization (TARE) for primary liver cancer (Hepato Cellular Carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA)). Patients are followed for 7 months to assess patient satisfaction, safety and clinical outcomes. A qualitative implementation study and a medico-economic evaluation (cost analysis and 5-years budget impact analysis) are embedded to assess acceptability, adoption, feasability, and sustainability and to inform scaling.
Eligibility
Primary outcome measure(s)
- Overall patient satisfaction — 72 hours after treatment procedure
EORTC PATSAT-C33 questionnaire. All items are scored 1 (bad) to 5 (excellent). The total score measures range in score from 0 to 100. A high score represents a high level of satisfaction with care / perceived care quality.
Trial sites (19)
| Facility | City | Region | Status |
|---|---|---|---|
| University hospital of Amiens | Amiens | France | Recruiting |
| University hospital of Angers | Angers | France | Recruiting |
| University hospital of Besançon | Besançon | France | Recruiting |
| Hospital of Avicennes (AP-HP) | Bobigny | France | Recruiting |
| University hospital of Brest | Brest | France | Recruiting |
| Hospital of Beaujon (AP-HP) | Clichy | France | Recruiting |
| Hospital of Vendée | La Roche-sur-Yon | France | Recruiting |
| University hospital of Grenoble-Alpes | La Tronche | France | Recruiting |
| University hospital of Marseille (AP-HM) | Marseille | France | Recruiting |
| Saint-Joseph Hospital | Marseille | France | Recruiting |
| University hospital of Montpellier | Montpellier | France | Not Yet Recruiting |
| University hospital of Nantes | Nantes | France | Not Yet Recruiting |
| University hospital of Nice | Nice | France | Recruiting |
| Saint-Antoine Hospital (AP-HP) | Paris | France | Recruiting |
| Hospital of Pitié-Salpétrière (AP-HP) | Paris | France | Recruiting |
| Hospital of Cochin (AP-HP) | Paris | France | Recruiting |
| Univesity hospital of Bordeaux | Pessac | France | Not Yet Recruiting |
| University hospital of Toulouse | Toulouse | France | Recruiting |
| Institut Gustave Roussy (IGR) | Villejuif | France | Recruiting |
More University Hospital, Angers trials in France
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06990659 on ClinicalTrials.gov ↗ ← All trials in France